- Exchange: Shanghai
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Shanghai Fosun Pharmaceutical Group Co Ltd
+ Add to Watchlist600196:CH
11.900 CNY 0.120 1.00%As of 03:05:07 ET on 05/23/2013.
Snapshot for Shanghai Fosun Pharmaceutical Group Co Ltd (600196)
| Open: | 11.960 | Day's Range: | 11.870 - 12.050 | Volume: | 14,075,269 |
|---|---|---|---|---|---|
| Previous Close: | 12.020 | 52wk Range: | 8.830 - 12.900 | 1-Yr Rtn: | +16.35% |
Key Statistics for 600196
| Current P/E Ratio (ttm) | 15.1960 |
|---|---|
| Estimated P/E(12/2013) | 13.7891 |
| Relative P/E vs. SHASHR | 1.2259 |
| Earnings Per Share (CNY) (ttm) | 0.7831 |
| Est. EPS (CNY) (12/2013) | 0.8630 |
| Est. PEG Ratio | - |
| Market Cap (M CNY) | 26,358.87 |
| Shares Outstanding (M) | 1,904.39 |
| 30 Day Average Volume | 15,190,740 |
| Price/Book (mrq) | 1.9126 |
| Price/Sale (ttm) | 3.1584 |
| Dividend Indicated Gross Yield | 1.76% |
| Cash Dividend (CNY) | 0.2100 |
| Last Dividend | |
| 5 Year Dividend Growth | 14.29% |
| Next Earnings Announcement | 03/26/2014 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 600196
Company Profile & Key Executives for 600196
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a pharmaceutical company. Through its subsidiaries, the Company manufactures genetic medicines, Chinese traditional medicines, diagnostic products, and medical instruments, provides technology, marketing, and advertising services, as well as invests in import and export trading.
| Chen QiyuChairman | Yao FangDeputy Chairman/President |
| Qiao ZhichengSenior VP/Controller/Secretary | Fan BanghanSenior Vice President |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
600196 News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page